285 related articles for article (PubMed ID: 25419568)
1. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
[TBL] [Abstract][Full Text] [Related]
2. [Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].
Li Z; Liu CP; He YL; Tian Y; Huang T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):547-9. PubMed ID: 18798490
[TBL] [Abstract][Full Text] [Related]
3. CD24(+) cells fuel rapid tumor growth and display high metastatic capacity.
Rostoker R; Abelson S; Genkin I; Ben-Shmuel S; Sachidanandam R; Scheinman EJ; Bitton-Worms K; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Breast Cancer Res; 2015 Jun; 17(1):78. PubMed ID: 26040280
[TBL] [Abstract][Full Text] [Related]
4. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.
Kim J; Villadsen R; Sørlie T; Fogh L; Grønlund SZ; Fridriksdottir AJ; Kuhn I; Rank F; Wielenga VT; Solvang H; Edwards PA; Børresen-Dale AL; Rønnov-Jessen L; Bissell MJ; Petersen OW
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6124-9. PubMed ID: 22454501
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
[TBL] [Abstract][Full Text] [Related]
7. Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.
Huber S; Wege AK; Bernhardt G; Buschauer A; Brockhoff G
Cytometry A; 2015 Aug; 87(8):707-16. PubMed ID: 25892097
[TBL] [Abstract][Full Text] [Related]
8. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.
Cho RW; Wang X; Diehn M; Shedden K; Chen GY; Sherlock G; Gurney A; Lewicki J; Clarke MF
Stem Cells; 2008 Feb; 26(2):364-71. PubMed ID: 17975224
[TBL] [Abstract][Full Text] [Related]
9. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
10. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
11. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
Hiraga T; Ito S; Nakamura H
Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938
[TBL] [Abstract][Full Text] [Related]
12. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
14. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
Rappa G; Lorico A
Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
[TBL] [Abstract][Full Text] [Related]
16. Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.
Mosoyan G; Nagi C; Marukian S; Teixeira A; Simonian A; Resnick-Silverman L; DiFeo A; Johnston D; Reynolds SR; Roses DF; Mosoian A
PLoS One; 2013; 8(1):e55145. PubMed ID: 23372829
[TBL] [Abstract][Full Text] [Related]
17. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
Appaiah H; Bhat-Nakshatri P; Mehta R; Thorat M; Badve S; Nakshatri H
Cancer Biol Ther; 2010 Sep; 10(6):600-14. PubMed ID: 20603605
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway.
Du Z; Li J; Wang L; Bian C; Wang Q; Liao L; Dou X; Bian X; Zhao RC
Cancer Sci; 2010 Nov; 101(11):2417-24. PubMed ID: 20950370
[TBL] [Abstract][Full Text] [Related]
19. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
Wu J; Crowe DL
Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
[TBL] [Abstract][Full Text] [Related]
20. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
